Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update.

Battipaglia, Giorgia; Massoud, Radwan; Ahmed, Syed Osman; Legrand, Ollivier; El Cheikh, Jean; Youniss, Riad; Aljurf, Mahmoud; Mohty, Mohamad; Bazarbachi, Ali

Battipaglia, Giorgia; Massoud, Radwan; Ahmed, Syed Osman; Legrand, Ollivier; El Cheikh, Jean; Youniss, Riad; Aljurf, Mahmoud; Mohty, Mohamad; Bazarbachi, Ali.

Afiliação

Battipaglia G; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France; Department of Hematology and Marrow Transplantation, University Federico II of Naples, Naples, Italy. Electronic address: giorgia.battipaglia@aphp.fr.
Massoud R; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Ahmed SO; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Legrand O; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.
El Cheikh J; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Youniss R; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Aljurf M; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Mohty M; Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France; Université Pierre and Marie Curie, Paris, France; INSERM, UMRs 938, Paris, France.
Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Department of Cell Biology, Anatomy and Physiological Sciences, American University of Beirut, Beirut, Lebanon.

Clin Lymphoma Myeloma Leuk ; 19(8): 506-508, 2019 08.

Article em En | MEDLINE | ID: mdl-31122828

Assuntos

Transplante de Células-Tronco Hematopoéticas/mortalidade; Leucemia Mieloide Aguda/tratamento farmacológico; Inibidores de Proteínas Quinases/uso terapêutico; Sorafenibe/uso terapêutico; Adolescente; Adulto; Estudos de Coortes; Terapia Combinada; Estudos de Viabilidade; Feminino; Seguimentos; Humanos; Leucemia Mieloide Aguda/genética; Leucemia Mieloide Aguda/patologia; Leucemia Mieloide Aguda/terapia; Quimioterapia de Manutenção; Masculino; Pessoa de Meia-Idade; Mutação; Prognóstico; Indução de Remissão; Taxa de Sobrevida; Transplante Homólogo; Adulto Jovem; Tirosina Quinase 3 Semelhante a fms/antagonistas & inibidores; Tirosina Quinase 3 Semelhante a fms/genética

Palavras-chave

Allogeneic stem cell transplantation; FLT3 mutated acute myeloid leukemia; Maintenance treatment; Sorafenib; Update

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Inibidores de Proteínas Quinases / Sorafenibe Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google